Journal of Clinical Immunology

, Volume 28, Issue 2, pp 186–193

Primary Immunodeficiency Disorders in Kuwait: First Report from Kuwait National Primary Immunodeficiency Registry (2004–2006)

Article

Abstract

Primary immunodeficiency disorders are heterogeneous group of illnesses that predispose patients to serious complications. Registries for these disorders have provided important epidemiological data and shown both racial and geographical variations. The clinical features of 76 patients with primary immunodeficiency disorders registered in Kuwait National Primary Immunodeficiency Registry from 2004 to 2006 were recorded. Ninety-eight percent of the patients presented in childhood. The prevalence of these disorders in children was 11.98 in 100,000 children with an incidence of 10.06 in 100,000 children. The distribution of these patients according to each primary immunodeficiency category is: combined T and B cell immunodeficiencies (21%), predominantly antibody immunodeficiency (30%), other well defined immunodeficiencies (30%), diseases of immune dysregulation (7%), congenital defects of phagocyte number, function or both (8%), and complement deficiencies (4%). The consanguinity rate within the registered patients was 77%. The patients had a wide range of clinical features affecting different body systems. Primary immunodeficiency disorders are prevalent in Kuwait and have a significant impact into the health system.

Keywords

Immunodeficiency registry epidemiology Arab Kuwait 

References

  1. 1.
    Ochs HD, Stiehm R, Winkelstein J. Antibody deficiencies. In: ER Stiehm, HD Ochs, JA Winkelstein, editors. Immunologic disorders in infants & children. 5th ed. Philadelphia: Elsevier Saunders; 2004. pp. 356–426.Google Scholar
  2. 2.
    Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. J Clin Immunol 1999;92:34–48.CrossRefGoogle Scholar
  3. 3.
    Woroniecka M, Ballow M. Office evaluation of children with recurrent infections. Pediatr Clin North Am 2000;47(6):1211–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000;343(18):1313–23.PubMedCrossRefGoogle Scholar
  5. 5.
    Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, et al. Primary immunodeficiency diseases: an update from international union of immunological societies primary immunodeficiency diseases classification committee meeting in Budapest, 2005. J Allergy Clin Immunol 2006;117:883–96.PubMedCrossRefGoogle Scholar
  6. 6.
    Tangsinmankong N, Bahna SL, Good RA. The immunologic workup of the child suspected of immunodeficiency. Ann Allergy Asthma Immunol 2001;87:362–70.PubMedCrossRefGoogle Scholar
  7. 7.
    Immune Deficiency Foundation Diagnosting & Clinical Care Guidelines for Primary immunodeficiency Diseases: http://www.primaryimmune.org (July 1, 2007).
  8. 8.
    Stiem ER, Chin TW, Hass A, Peerless AG. Infectious complications of primary immunodeficiencies. Clin Immunol Immunopathol 1986;40:69–89.CrossRefGoogle Scholar
  9. 9.
    Webster ABD. Infection in primary immunodeficiency syndrome. Curr Opin Infect Dis 1994;7:444–9.CrossRefGoogle Scholar
  10. 10.
    Knutsen AP, Wall DA. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol 2000;20:466–76.PubMedCrossRefGoogle Scholar
  11. 11.
    Cavazzana-Calvo M, Hacein-Bay S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000;288:669–72.PubMedCrossRefGoogle Scholar
  12. 12.
    Buckley RH. A historical review of bone marrow transplantation for primary immunodeficiencies. J Allergy Clin Immunol 2004;113(4):793–800.PubMedCrossRefGoogle Scholar
  13. 13.
    Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharazlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol 2006;26(6):519–32.PubMedCrossRefGoogle Scholar
  14. 14.
    Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Caravalho BT, et al. Primary immunodeficiency diseases in Latin America: The second report of the LAGID registry. J Clin Immunol 2007;27(1):101–8.PubMedCrossRefGoogle Scholar
  15. 15.
    The European Society for Immunodeficiencies: http://www.esid.org/statistics.php (July 15, 2007).
  16. 16.
    Lee WI, Kuo ML, Huang JL, Lin SJ, Wu CJ. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol 2005;25(2):162–73.PubMedCrossRefGoogle Scholar
  17. 17.
    Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J Clin Immunol 2005;25(1):73–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Mila LIambi J, Etxagibel Galdos A, Matamoros Flori N. The Spanish Registry of Primay Immunodeficiencies (REDIP). Allergol Immunopathol 2001;29(3):122–5.Google Scholar
  19. 19.
    Al-Attas RA, Rahi AH. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. J Clin Immunol 1998;18(5):368–71.PubMedCrossRefGoogle Scholar
  20. 20.
    Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of immunodeficiency disorders in Australia. J Allergy Clin Immunol 1997;100(3):415–23.PubMedCrossRefGoogle Scholar
  21. 21.
    Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol 1988;8(6):479–85.PubMedCrossRefGoogle Scholar
  22. 22.
    Luzi G, Pesce AM, Rinaldi S. Primary immunodeficiencies in Italy. Data revised from the Italian Register of Immunodeficiencies-IRID (1977–88). Allergol Immunopathol 1991;19(2):53–7.Google Scholar
  23. 23.
    Hayakawa H, Iwata T, Yata J, Kobayashi N. Primay immunodefiedncy syndrome in Japan. Overview of a nationwide survey on primary immunodeficiency syndrome. J Clin Immunol 1981;1(1):31–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Fasth A. Primary immunodeficiency disorders in Sweden: cases among children 1974–1979. J Clin Immunol 1982;2:86–92.PubMedCrossRefGoogle Scholar
  25. 25.
    Stary-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol 2000;20(6):477–84.CrossRefGoogle Scholar
  26. 26.
    Kuwait Health 2004–2006. Health & Vital Statistics Division, Department of Statistics & Medical Records. Ministry of Health, State of Kuwait.Google Scholar
  27. 27.
    White AG, Raju KT, Abouna GM. A six year experience with recurrent infections and immunodeficiency in children in Kuwait. J Clin Lab Immunol 1988;26(2):97–101.PubMedGoogle Scholar
  28. 28.
    Zimran A, Rudensky B, Kramer MR. Hereditary complement deficiency in survivors of meningococcal disease. High prevalence of C7/C8 deficiency in Sphardic (Moroccan) Jews. Q I Med 1987;63:349–58.Google Scholar
  29. 29.
    Schlesinger M, Nave Z, Levi Y, Fishelson Z. Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections. Clin Exp Immunol 1990;81:423–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Elder ME. T-cell immunodeficiencies. Pediatr Clin North Am 2000;47(6):1253–73.PubMedCrossRefGoogle Scholar
  31. 31.
    Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospectic survey of 31 patients. J Pediatr 1999;134:589–96.PubMedCrossRefGoogle Scholar
  32. 32.
    Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002;109:1001–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Stadtmauer G, Cunningham-Rundles C. Outcome analysis and cost assessment in immunologic disorders. JAMA 1997;278:2018–23.PubMedCrossRefGoogle Scholar
  34. 34.
    Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr 2002;141:566–71.PubMedCrossRefGoogle Scholar
  35. 35.
    Jeffrey Modell Foundation: http://www.jmfworld.com/ (July 15, 2007).
  36. 36.
    Buckley RH, Schiff SE, Schiff RI, Market L, Williams LW, Roberts JL, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999;340:508–16.PubMedCrossRefGoogle Scholar
  37. 37.
    Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002;99:872–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, et al.; European Group for Blood and Marrow Transplantatoin; European Society for Immunodeficiency. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 2003;361:553–60.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Allergy & Clinical Immunology Unit, Pediatrics DepartmentAl-Sabah HospitalKuwait cityKuwait
  2. 2.KuwaitKuwait

Personalised recommendations